Clinical trial
A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)
NCT04834778
Study timeline
Study start (actual)2021-06-08Date precision: day
Registry last updated2024-03-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Renal Cell Carcinomaunresolved
Gastric Cancerunresolved
Metastatic Breast Cancerunresolved
Small-cell Lung Cancerunresolved
Other Solid Tumorsunresolved
Interventions
HC-5404-FUDRUG
Sponsors & collaborators
HiberCell, Inc.lead sponsor
Covancecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04834778 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.